Showing results (1871-1880 of 2,166) with videos related to

Sort By:
Pageof 217
Head & Neck|April 3, 2023
Tumor volume as a predictor of survival in advanced laryngeal cancer treated with total laryngectomyKrishna S Hanubal, Zhanna Galochkina, Ji-Hyun Lee, et al.
Frontiers in Cardiovascular Medicine|August 30, 2023
Catheter ablation of concomitant atrial fibrillation improves survival of patients undergoing transcatheter edge-to-edge mitral valve repairFelix Ausbuettel, Sebastian Barth, Georgios Chatzis, et al.
Translational Oncology|April 30, 2026
Growth hormone receptor antagonism improves tumoral chemo-immunotherapy response in a mouse model of lung cancerArshad Ahmad, Reetobrata Basu, Caden Fyffe, et al.
Nucleic Acids Research|November 17, 2025
Mapping drug mechanisms with ProteomicsDB: unified omics and cell sensitivity data at scaleMario Picciani, Armin Soleymaniniya, Julian Müller, et al.
Genome Biology|December 15, 2021
Flimma: a federated and privacy-aware tool for differential gene expression analysisOlga Zolotareva, Reza Nasirigerdeh, Julian Matschinske, et al.
Health Policy and Planning|April 13, 2017
The effect of health insurance and health facility-upgrades on hospital deliveries in rural Nigeria: a controlled interrupted time-series studyDaniëlla Brals, Sunday A Aderibigbe, Ferdinand W Wit, et al.
Endocrinology|May 26, 2022
Excess Growth Hormone Alters the Male Mouse Gut Microbiome in an Age-dependent MannerElizabeth A Jensen, Jonathan A Young, Zachary Jackson, et al.
Blood|July 20, 2007
Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromesAzim Mohamedali, Joop Gäken, Natalie A Twine, et al.
EMBO Reports|June 12, 2026
SATB1 is a targetable modulator of JAK-STAT signaling and cytokines in human Treg and Tconv cellsSaskia Kolb, Leonie Diekmann, Elizabeth E Lochert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancerDaniel J Haraf, Fred R Rosen, Kerstin Stenson, et al.
Pageof 217